array(40) {
  [0]=>
  string(4) "9390"
  ["article_id"]=>
  string(4) "9390"
  [1]=>
  string(44) "Using AI to accurately analyse blood samples"
  ["article_title"]=>
  string(44) "Using AI to accurately analyse blood samples"
  [2]=>
  string(150) "In this episode of The MedTalk Podcast, you can hear Olivia Friett, editor of Medical Plastics News talk to Dr. Murdoc Khaleghi, chief medical officer"
  ["short_description"]=>
  string(150) "In this episode of The MedTalk Podcast, you can hear Olivia Friett, editor of Medical Plastics News talk to Dr. Murdoc Khaleghi, chief medical officer"
  [3]=>
  string(224) "In this episode of The MedTalk Podcast, you can hear Olivia Friett, editor of Medical Plastics News talk to Dr. Murdoc Khaleghi, chief medical officer for Molecular You about the latest technology in AI driven blood testing."
  ["description"]=>
  string(224) "In this episode of The MedTalk Podcast, you can hear Olivia Friett, editor of Medical Plastics News talk to Dr. Murdoc Khaleghi, chief medical officer for Molecular You about the latest technology in AI driven blood testing."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(119) "https://www.medicalplasticsnews.com/medical-plastics-resources/MedTalkPod/using-ai-to-accurately-analyse-blood-samples/"
  ["blog_url"]=>
  string(119) "https://www.medicalplasticsnews.com/medical-plastics-resources/MedTalkPod/using-ai-to-accurately-analyse-blood-samples/"
  [15]=>
  string(19) "2024-08-20 17:00:00"
  ["add_date"]=>
  string(19) "2024-08-20 17:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9367"
  ["article_id"]=>
  string(4) "9367"
  [1]=>
  string(52) "Coloplast A/S - Interim Financial Report, 9M 2023/24"
  ["article_title"]=>
  string(52) "Coloplast A/S - Interim Financial Report, 9M 2023/24"
  [2]=>
  string(76) "9M 2023/24Interim financial results, 9M 2023/241 October 2023 - 30 June 2024"
  ["short_description"]=>
  string(76) "9M 2023/24Interim financial results, 9M 2023/241 October 2023 - 30 June 2024"
  [3]=>
  string(125) "
9M 2023/24
Interim financial results, 9M 2023/24
1 October 2023 - 30 June 2024
"
  ["description"]=>
  string(125) "
9M 2023/24
Interim financial results, 9M 2023/24
1 October 2023 - 30 June 2024
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(121) "https://www.globenewswire.com/news-release/2024/08/20/2932526/0/en/Coloplast-A-S-Interim-Financial-Report-9M-2023-24.html"
  ["blog_url"]=>
  string(121) "https://www.globenewswire.com/news-release/2024/08/20/2932526/0/en/Coloplast-A-S-Interim-Financial-Report-9M-2023-24.html"
  [15]=>
  string(19) "2024-08-20 13:33:00"
  ["add_date"]=>
  string(19) "2024-08-20 13:33:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:22"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9368"
  ["article_id"]=>
  string(4) "9368"
  [1]=>
  string(47) "Coloplast A/S - Regnskabsmeddelelse, 9M 2023/24"
  ["article_title"]=>
  string(47) "Coloplast A/S - Regnskabsmeddelelse, 9M 2023/24"
  [2]=>
  string(76) "9M 2023/24Delårsrapport, 9M 2023/241. oktober 2023 – 30. juni 2024"
  ["short_description"]=>
  string(76) "9M 2023/24Delårsrapport, 9M 2023/241. oktober 2023 – 30. juni 2024"
  [3]=>
  string(125) "
9M 2023/24
Delårsrapport, 9M 2023/24
1. oktober 2023 – 30. juni 2024
"
  ["description"]=>
  string(125) "
9M 2023/24
Delårsrapport, 9M 2023/24
1. oktober 2023 – 30. juni 2024
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(116) "https://www.globenewswire.com/news-release/2024/08/20/2932526/0/da/Coloplast-A-S-Regnskabsmeddelelse-9M-2023-24.html"
  ["blog_url"]=>
  string(116) "https://www.globenewswire.com/news-release/2024/08/20/2932526/0/da/Coloplast-A-S-Regnskabsmeddelelse-9M-2023-24.html"
  [15]=>
  string(19) "2024-08-20 13:33:00"
  ["add_date"]=>
  string(19) "2024-08-20 13:33:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:22"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9330"
  ["article_id"]=>
  string(4) "9330"
  [1]=>
  string(50) "Quick Notes: Drug Approvals — Aug. 19, 2024"
  ["article_title"]=>
  string(50) "Quick Notes: Drug Approvals — Aug. 19, 2024"
  [2]=>
  string(168) "&#nl        This edition of Quick Notes features approvals for Adaptimmune’s Tecelra, Purdue Pharma’s Zurnai, Servier Pharmaceuticals’ Voranigo and"
  ["short_description"]=>
  string(168) "&#nl        This edition of Quick Notes features approvals for Adaptimmune’s Tecelra, Purdue Pharma’s Zurnai, Servier Pharmaceuticals’ Voranigo and"
  [3]=>
  string(208) "&#nl        This edition of Quick Notes features approvals for Adaptimmune’s Tecelra, Purdue Pharma’s Zurnai, Servier Pharmaceuticals’ Voranigo and Aurobindo’s Estradiol.&#nl      "
  ["description"]=>
  string(208) "&#nl        This edition of Quick Notes features approvals for Adaptimmune’s Tecelra, Purdue Pharma’s Zurnai, Servier Pharmaceuticals’ Voranigo and Aurobindo’s Estradiol.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(78) "https://www.fdanews.com/articles/214029-quick-notes-drug-approvals-aug-19-2024"
  ["blog_url"]=>
  string(78) "https://www.fdanews.com/articles/214029-quick-notes-drug-approvals-aug-19-2024"
  [15]=>
  string(19) "2024-08-20 00:35:04"
  ["add_date"]=>
  string(19) "2024-08-20 00:35:04"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:19:04"
  ["create_at"]=>
  string(19) "2024-08-24 15:19:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9331"
  ["article_id"]=>
  string(4) "9331"
  [1]=>
  string(81) "US Distributor of Tainted Eye Drops Gets FDA Warning Letter for Failure to Recall"
  ["article_title"]=>
  string(81) "US Distributor of Tainted Eye Drops Gets FDA Warning Letter for Failure to Recall"
  [2]=>
  string(163) "&#nl        Velocity Pharma’s lack of oversight of the quality of the eye drops its contract manufacturer — Kilitch Healthcare India Limited who rece"
  ["short_description"]=>
  string(163) "&#nl        Velocity Pharma’s lack of oversight of the quality of the eye drops its contract manufacturer — Kilitch Healthcare India Limited who rece"
  [3]=>
  string(264) "&#nl        Velocity Pharma’s lack of oversight of the quality of the eye drops its contract manufacturer — Kilitch Healthcare India Limited who received its own Warning Letter for the eye drops — has earned it an FDA Warning Letter.&#nl      "
  ["description"]=>
  string(264) "&#nl        Velocity Pharma’s lack of oversight of the quality of the eye drops its contract manufacturer — Kilitch Healthcare India Limited who received its own Warning Letter for the eye drops — has earned it an FDA Warning Letter.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(121) "https://www.fdanews.com/articles/214028-us-distributor-of-tainted-eye-drops-gets-fda-warning-letter-for-failure-to-recall"
  ["blog_url"]=>
  string(121) "https://www.fdanews.com/articles/214028-us-distributor-of-tainted-eye-drops-gets-fda-warning-letter-for-failure-to-recall"
  [15]=>
  string(19) "2024-08-20 00:30:15"
  ["add_date"]=>
  string(19) "2024-08-20 00:30:15"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:19:04"
  ["create_at"]=>
  string(19) "2024-08-24 15:19:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9436"
  ["article_id"]=>
  string(4) "9436"
  [1]=>
  string(68) "AI-powered RPM boosts care for chronic conditions while saving costs"
  ["article_title"]=>
  string(68) "AI-powered RPM boosts care for chronic conditions while saving costs"
  [2]=>
  string(150) "Artificial intelligence is helping improve remote patient monitoring technology, with especially promising applications focused on diabetes. One CEO d"
  ["short_description"]=>
  string(150) "Artificial intelligence is helping improve remote patient monitoring technology, with especially promising applications focused on diabetes. One CEO d"
  [3]=>
  string(251) "Artificial intelligence is helping improve remote patient monitoring technology, with especially promising applications focused on diabetes. One CEO discusses the quality and cost-efficiency promise of "the next generation of remote care."&#nl"
  ["description"]=>
  string(251) "Artificial intelligence is helping improve remote patient monitoring technology, with especially promising applications focused on diabetes. One CEO discusses the quality and cost-efficiency promise of "the next generation of remote care."&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(102) "https://www.healthcareitnews.com/news/ai-powered-rpm-boosts-care-chronic-conditions-while-saving-costs"
  ["blog_url"]=>
  string(102) "https://www.healthcareitnews.com/news/ai-powered-rpm-boosts-care-chronic-conditions-while-saving-costs"
  [15]=>
  string(19) "2024-08-20 00:28:25"
  ["add_date"]=>
  string(19) "2024-08-20 00:28:25"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:43"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:43"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9391"
  ["article_id"]=>
  string(4) "9391"
  [1]=>
  string(56) "The impact of ISO 13485 on medical battery manufacturing"
  ["article_title"]=>
  string(56) "The impact of ISO 13485 on medical battery manufacturing"
  [2]=>
  string(150) "ISO 13485 is an internationally recognised standard that sets out the requirements for a quality management system (QMS) for the design and manufactur"
  ["short_description"]=>
  string(150) "ISO 13485 is an internationally recognised standard that sets out the requirements for a quality management system (QMS) for the design and manufactur"
  [3]=>
  string(248) "ISO 13485 is an internationally recognised standard that sets out the requirements for a quality management system (QMS) for the design and manufacture of medical devices. Daniel Gardiner, quality manager, Alexander Battery Technologies, discusses."
  ["description"]=>
  string(248) "ISO 13485 is an internationally recognised standard that sets out the requirements for a quality management system (QMS) for the design and manufacture of medical devices. Daniel Gardiner, quality manager, Alexander Battery Technologies, discusses."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(165) "https://www.medicalplasticsnews.com/medical-plastics-industry-insights/medical-plastics-regulatory-insights/the-impact-of-iso-13485-on-medical-battery-manufacturing/"
  ["blog_url"]=>
  string(165) "https://www.medicalplasticsnews.com/medical-plastics-industry-insights/medical-plastics-regulatory-insights/the-impact-of-iso-13485-on-medical-battery-manufacturing/"
  [15]=>
  string(19) "2024-08-19 23:00:58"
  ["add_date"]=>
  string(19) "2024-08-19 23:00:58"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9437"
  ["article_id"]=>
  string(4) "9437"
  [1]=>
  string(58) "Carequality to align interoperability strategy with TEFCA "
  ["article_title"]=>
  string(58) "Carequality to align interoperability strategy with TEFCA "
  [2]=>
  string(150) "Epic is applauding the move, and says it expects that all of its clients nationwide will be live on the exchange framework by the end of next year, vi"
  ["short_description"]=>
  string(150) "Epic is applauding the move, and says it expects that all of its clients nationwide will be live on the exchange framework by the end of next year, vi"
  [3]=>
  string(208) "Epic is applauding the move, and says it expects that all of its clients nationwide will be live on the exchange framework by the end of next year, via its Epic Nexus qualified health information network.&#nl"
  ["description"]=>
  string(208) "Epic is applauding the move, and says it expects that all of its clients nationwide will be live on the exchange framework by the end of next year, via its Epic Nexus qualified health information network.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(87) "https://www.healthcareitnews.com/news/carequality-align-interoperability-strategy-tefca"
  ["blog_url"]=>
  string(87) "https://www.healthcareitnews.com/news/carequality-align-interoperability-strategy-tefca"
  [15]=>
  string(19) "2024-08-19 22:15:54"
  ["add_date"]=>
  string(19) "2024-08-19 22:15:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:43"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:43"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9369"
  ["article_id"]=>
  string(4) "9369"
  [1]=>
  string(53) "United Health Products Submits Response Letter to FDA"
  ["article_title"]=>
  string(53) "United Health Products Submits Response Letter to FDA"
  [2]=>
  string(157) "MT. LAUREL, NJ, Aug.  19, 2024  (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premar"
  ["short_description"]=>
  string(157) "MT. LAUREL, NJ, Aug.  19, 2024  (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premar"
  [3]=>
  string(234) "
MT. LAUREL, NJ, Aug.  19, 2024  (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process.  
"
  ["description"]=>
  string(234) "
MT. LAUREL, NJ, Aug.  19, 2024  (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process.  
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(125) "https://www.globenewswire.com/news-release/2024/08/19/2932162/0/en/United-Health-Products-Submits-Response-Letter-to-FDA.html"
  ["blog_url"]=>
  string(125) "https://www.globenewswire.com/news-release/2024/08/19/2932162/0/en/United-Health-Products-Submits-Response-Letter-to-FDA.html"
  [15]=>
  string(19) "2024-08-19 21:09:00"
  ["add_date"]=>
  string(19) "2024-08-19 21:09:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:22"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9318"
  ["article_id"]=>
  string(4) "9318"
  [1]=>
  string(59) "Oncimmune announces new contract with global pharma company"
  ["article_title"]=>
  string(59) "Oncimmune announces new contract with global pharma company"
  [2]=>
  string(86) "The contract concerns profiling Immunoglobulin E autoantibodies in blood serum&#nl&#nl"
  ["short_description"]=>
  string(86) "The contract concerns profiling Immunoglobulin E autoantibodies in blood serum&#nl&#nl"
  [3]=>
  string(237) "
The contract concerns profiling Immunoglobulin E autoantibodies in blood serum
&#nl
&#nl"
  ["description"]=>
  string(237) "
The contract concerns profiling Immunoglobulin E autoantibodies in blood serum
&#nl
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(89) "https://pharmatimes.com/news/oncimmune-announces-new-contract-with-global-pharma-company/"
  ["blog_url"]=>
  string(89) "https://pharmatimes.com/news/oncimmune-announces-new-contract-with-global-pharma-company/"
  [15]=>
  string(19) "2024-08-19 19:25:06"
  ["add_date"]=>
  string(19) "2024-08-19 19:25:06"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:19:00"
  ["create_at"]=>
  string(19) "2024-08-24 15:19:00"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9384"
  ["article_id"]=>
  string(4) "9384"
  [1]=>
  string(79) "Glycocalyx supplement may improve cardiovascular health for psoriasis sufferers"
  ["article_title"]=>
  string(79) "Glycocalyx supplement may improve cardiovascular health for psoriasis sufferers"
  [2]=>
  string(150) "A glycocalyx dietary supplement (GDS) marketed as Endocalyx-Pro may improve vascular integrity and arterial stiffness in people with psoriasis, says a"
  ["short_description"]=>
  string(150) "A glycocalyx dietary supplement (GDS) marketed as Endocalyx-Pro may improve vascular integrity and arterial stiffness in people with psoriasis, says a"
  [3]=>
  string(199) "A glycocalyx dietary supplement (GDS) marketed as Endocalyx-Pro may improve vascular integrity and arterial stiffness in people with psoriasis, says a joint study from Greek and American researchers."
  ["description"]=>
  string(199) "A glycocalyx dietary supplement (GDS) marketed as Endocalyx-Pro may improve vascular integrity and arterial stiffness in people with psoriasis, says a joint study from Greek and American researchers."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(170) "https://www.nutraingredients.com/Article/2024/08/19/glycocalyx-may-support-cardiovascular-health-in-psoriasis-patients?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(170) "https://www.nutraingredients.com/Article/2024/08/19/glycocalyx-may-support-cardiovascular-health-in-psoriasis-patients?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-19 18:57:00"
  ["add_date"]=>
  string(19) "2024-08-19 18:57:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:29"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:29"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9392"
  ["article_id"]=>
  string(4) "9392"
  [1]=>
  string(32) "New medtech consultancy launched"
  ["article_title"]=>
  string(32) "New medtech consultancy launched"
  [2]=>
  string(150) "Archetype, a medtech innovation management consultancy, has launched, with a commitment to guide innovators through the process of securing market app"
  ["short_description"]=>
  string(150) "Archetype, a medtech innovation management consultancy, has launched, with a commitment to guide innovators through the process of securing market app"
  [3]=>
  string(186) "Archetype, a medtech innovation management consultancy, has launched, with a commitment to guide innovators through the process of securing market approval for their medical innovations."
  ["description"]=>
  string(186) "Archetype, a medtech innovation management consultancy, has launched, with a commitment to guide innovators through the process of securing market approval for their medical innovations."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(114) "https://www.medicalplasticsnews.com/news/medical-plastics-regulatory-policy-news/new-medtech-consultancy-launched/"
  ["blog_url"]=>
  string(114) "https://www.medicalplasticsnews.com/news/medical-plastics-regulatory-policy-news/new-medtech-consultancy-launched/"
  [15]=>
  string(19) "2024-08-19 18:00:00"
  ["add_date"]=>
  string(19) "2024-08-19 18:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}